Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 6,847 $ 4,072
Premium and trade receivables 4,647 3,413
Short-term investments 594 531
Other current assets 1,000 687
Total current assets 13,088 8,703
Long-term investments 6,272 5,312
Restricted deposits 550 135
Property, software and equipment, net 1,584 1,104
Goodwill 6,803 4,749
Intangible assets, net 2,423 1,398
Other long-term assets 437 454
Total assets 31,157 21,855
Current liabilities:    
Medical claims liability 6,983 4,286
Accounts payable and accrued expenses 4,550 4,165
Return of premium payable 918 549
Unearned revenue 286 328
Current portion of long-term debt 4 4
Total current liabilities 12,741 9,332
Long-term debt 6,379 4,695
Other long-term liabilities 1,276 952
Total liabilities 20,396 14,979
Commitments and contingencies
Redeemable noncontrolling interests 11 12
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2018 and December 31, 2017 0 0
Common stock, $0.001 par value; authorized 400,000 shares; 207,550 issued and 205,354 outstanding at September 30, 2018, and 180,379 issued and 173,437 outstanding at December 31, 2017 0 0
Additional paid-in capital 7,395 4,349
Accumulated other comprehensive loss (79) (3)
Retained earnings 3,422 2,748
Treasury stock, at cost (2,196 and 6,942 shares, respectively) (85) (244)
Total Centene stockholders’ equity 10,653 6,850
Noncontrolling interest 97 14
Total stockholders’ equity 10,750 6,864
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 31,157 $ 21,855